post-add
author-image

Shivam Tyagi

Author

The author works as a Correspondent with BW Businessworld

Latest Articles By Shivam Tyagi

Glenmark Settles Class Action Lawsuit In US Court Related With Drug Zetia For $87.5 Mn

On Tuesday Glenmark Pharmaceuticals stated in an exchange filing that it has agreed to enter into a settlement with the three plaintiff groups who had filed a class action lawsuit against the company in the US court for a total amount of USD 87.5 million related to the generic drug Zetia

Read More
Quality Products Strengthen Global Demand For Medical Devices Manufactured in India: Chaitanya Sarawate

In an exclusive interaction with BW Healthcare World, Chaitanya Sarawate, President and CEO, GE HealthCare South Asia and Managing Director, Wipro GE Healthcare, speaks on key digital pillars for healthcare, Chat GPT, reducing import dependence of Indian MedTech, and future plans of his company

Read More
Health Insurance Expected To Cross 4-4.5 Lakh Cr In Gross Written Premiums By 2030: Star Health's Dr S Prakash

In an exclusive interaction with BW Healthcare World, Dr S Prakash, MD, Star Health and Allied Insurance speaks on the post-pandemic changes in the industry, health insurance industry's growth, OPD & maternity services in health policies and future plans of the company

Read More
World Health Day: Cancer In India On A Steep Rise, Comprehensive Healthcare Is A Necessity

According to a 2022 study published in the Indian Journal of Medical Research, the estimated number of incident cases of cancer in India for the year 2022 were found to be 14,61,427 with one in nine people likely to develop cancer in their lifetime

Read More
The Whole System Has To Change For Outcome Based Payments: Dr Ashutosh Raghuvanshi

In an exclusive interaction with BW Businessworld, Dr Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare delineates on the growth of the hospital industry, outcome based payment model, slashing costs, PPP models and the hospital chain’s plans for expansion & acquisitions

Read More
Hurting Generic Industry Compelling Pharma To Spend More On R&D

Industry experts contend that largely the research budgets of the top firms have remained flattish in the last two to three years on account of Covid, but the scenario might be changing for some select firms like Sun Pharmaceuticals, Dr Reddy’s Labs, Zydus Lifesciences, Cipla and Biocon Biologics among others due a hurting generic pharma industry

Read More
BW Exclusive | Tuberculosis Related To Socio-economic Status Of Patients: Dr Bornali Datta, Medanta Hospitals

In an exclusive interaction with BW Healthcare World, Dr Bornali Datta, Director, Respiratory Medicine, at Medanta Hospital speaks on the country's fight against tuberculosis, the 2025 TB elimination goal, corporate responsibility and the message for TB patients

Read More
Krsnaa Diagnostics Wins Rs 450 Cr Tender Under National Health Mission

Krsnaa Diagnostics on Monday said that it has emerged as the lowest bidder for a tender put up by National Health Mission, Rajasthan and the diagnostic company bagged the tender for providing laboratory services in the entire state of Rajasthan under the mission

Read More
India Must Focus On Biopharmaceuticals To Feed The Growth Engine: Kiran Mazumdar Shaw

In an exclusive conversation with BW Healthcare World, Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Biocon Biologics delineates on how Indian pharma can move up the value chain, while also speaking on Biocon's R&D investments and future plans

Read More
E-pharmacies Might Go Down, Industry Expert Says Shutting Shops Not A Solution

Online pharmacies in India like Tata 1mg, Netmeds and Pharmeasy among others are in troubled waters again as media reports say that the pharmacies might face a complete ban over the online sale of drugs for alleged violation of norms

Read More